Krishna Institute Of Medical Sciences Profile
Key Indicators
- Authorised Capital ₹ 95.00 Cr
- Paid Up Capital ₹ 80.03 Cr
- Company Age 51 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 873.60 Cr
- Satisfied Charges ₹ 1,543.18 Cr
- Revenue Growth -1.03%
- Profit Growth -9.30%
- Ebitda -9.07%
- Net Worth 18.39%
- Total Assets 15.51%
About Krishna Institute Of Medical Sciences
Krishna Institute Of Medical Sciences Limited (KIOMSL) was founded in India on 26 July 1973 and has a glorious history of 51 years and six months. Its registered office is in Hyderabad, Telangana, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 543308.
The Corporate was formerly known as Jagjit Singh And Sons Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 95.00 Cr and a paid-up capital of Rs 80.03 Cr.
The company currently has active open charges totaling ₹873.60 Cr. The company has closed loans amounting to ₹1,543.18 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Krishna Institute Of Medical Sciences Limited India are Mantha Uma as Company Secretary, Sachin Salvi as Cfo, and Bollineni Abhinay as Ceo. Bhaskara Bollineni, Dandamudi Anitha, Kaza Kishore, and Five other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L55101TG1973PLC040558
- Company No.
040558
- Stock Symbol
BSE : 543308
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
26 Jul 1973
- Date of AGM
29 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Krishna Institute Of Medical Sciences?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mantha Uma | Company Secretary | 01-Jul-2015 | Current |
Bhaskara Bollineni  | Managing Director | 01-Nov-2002 | Current |
| Sachin Salvi | CFO | 01-Aug-2023 | Current |
| Bollineni Abhinay | CEO | 03-Jul-2019 | Current |
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Saumen Chakraborty | Director | 08-Jan-2021 | Current |
| Dandamudi Anitha | Whole-Time Director | 21-Mar-2008 | Current |
| Kaza Kishore | Director | 08-Jan-2021 | Current |
| Bollineni Abhinay | Director and Ceo | 18-Jan-2019 | Current |
| Venkata Jasthi | Director | 08-Jan-2021 | Current |
| Prameela Yalamanchili | Director | 19-May-2022 | Current |
Financial Performance of Krishna Institute Of Medical Sciences.
Krishna Institute Of Medical Sciences Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.03% decrease. The company also saw a slight decrease in profitability, with a 9.3% decrease in profit. The company's net worth Soared by an impressive increase of 18.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Krishna Institute Of Medical Sciences?
In 2021, Krishna Institute Of Medical Sciences had a promoter holding of 37.17% and a public holding of 62.83%. The company had 8 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Iirm Holdings India LimitedVenkata Jasthi is a mutual person
Formel Labs Private LimitedDandamudi Anitha is a mutual person
Suven Pharmaceuticals LimitedVenkata Jasthi is a mutual person
Endiya Trustee Private LimitedVenkata Jasthi is a mutual person
Premas Biotech Private LimitedSaumen Chakraborty is a mutual person
Avanti Frozen Foods Private LimitedPrameela Yalamanchili is a mutual person
Charges (Loans)
₹873.60 Cr
₹1,543.18 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 520.00 Cr
- Others : 327.10 Cr
- Hdfc Bank Limited : 26.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 May 2024 | Others | ₹150.00 Cr | Open |
| 15 Apr 2024 | Others | ₹150.00 Cr | Open |
| 08 Jun 2023 | Axis Bank Limited | ₹520.00 Cr | Open |
| 27 Mar 2020 | Hdfc Bank Limited | ₹26.50 Cr | Open |
| 31 Oct 2017 | Others | ₹27.10 Cr | Open |
How Many Employees Work at Krishna Institute Of Medical Sciences?
Krishna Institute Of Medical Sciences has a workforce of 4711 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Krishna Institute Of Medical Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krishna Institute Of Medical Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
